Article
Point of view: Genomic landscape and molecularly informed therapy in thymic carcinoma and other advanced thymic epithelial tumors.
Med (New York, N.Y.) - 13 Jun 2025
Conforti Fabio, De Pas Tommaso
Abstract excerpt
In this issue of Med,1 Möhrmann et al. present a comprehensive analysis of 81 advanced thymic epithelial tumors (TETs). The study offers insights into the tumor mutational landscape, germline alterations, and the identification of different immunological subsets. An interesting finding is the identification of "hot" and "cold" subsets of thymic carcinoma (TC), the hot subset showing better outcome with immune...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
